Clinical trials
Phase 2 Philadelphia Chromosome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2022 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Nanfang Hospital, Southern Medical University | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Goethe University | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Japan Adult Leukemia Study Group | 1 |
| M.D. Anderson Cancer Center | 1 |
| Norwegian University of Science and Technology | 1 |
| Pfizer | 1 |
| Rennes University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Philadelphia Chromosome | 17 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 12 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 9 |
| Leukemia | 4 |
| Leukemia, Myeloid, Acute | 3 |
| Blast Crisis | 2 |
| Neoplasm, Residual | 2 |
| Leukemia, Biphenotypic, Acute | 1 |
Trials
Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.